Breast Cancer

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy
Subclonal evolution during primary breast cancer treatment is largely unexplored. We aimed to assess the dynamic changes in subclonal …
PDF Cite Project Link
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.
PDF Cite Project Link